DMA,
Quote
Several very hopeful prospects such as Relenza for flu and Lotronex for irritable bowel syndrome failed in the later stages of testing or did not prove to be commercially viable.
end quote
Those tests would have been done a few years ago when bird flu was not mentioned it's a different scenario now therefore antivirals will play a big part in todays market IMO.
cheers
